This study is in progress, not accepting new patients
A Phase 1/2 Study to Evaluate Axatilimab in Participants With Active cGVHD
Summary
- Eligibility
- for people ages 6 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedcompletion around
- Principal Investigator
- by Wanxing Chai-ho (ucla)
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at University of California Health
- Wanxing Chai-ho (ucla)
HS Assistant Clinical Professor, Medicine. Authored (or co-authored) 13 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Syndax Pharmaceuticals
- ID
- NCT03604692
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- About 41 people participating
- Last Updated